Jason A. Clemens, former Chief Financial Officer of AdaptHealth Corp., filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 60,978 shares of AdaptHealth common stock through Morgan Stanley Smith Barney LLC.
Key Highlights
- Proposed sale: 60,978 shares of AdaptHealth Corp. common stock with an aggregate market value of $447,510.44, according to the filing.
- Seller: Jason A. Clemens, identified in the filing as former CFO of AdaptHealth Corp.
- Approximate sale date: November 6, 2026, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY.
- Shares outstanding: The filing states 136,525,348 shares of common stock outstanding at the time of notice.
- Prior sales: Clemens sold 169,779 shares on November 5, 2026, with gross proceeds of $1,260,743.41, as reported in the filing's three-month sales history.
- Source of shares: The shares were acquired through restricted stock vestings under a registered plan from the issuer, with vesting dates of February 28, 2024; October 11, 2024; and February 1, 2025, for services rendered.
AdaptHealth Former CFO Proposes Rule 144 Share Sale
According to the Form 144 notice filed with the U.S. Securities and Exchange Commission, Jason A. Clemens, the former Chief Financial Officer of AdaptHealth Corp. (NASDAQ:AHCO), is proposing to sell 60,978 shares of the company's common stock. The filing lists an aggregate market value of $447,510.44 for the proposed sale. The notice was dated November 6, 2026, and the approximate date of sale is listed as November 6, 2026.
The filing discloses that the shares to be sold were acquired through multiple restricted stock vestings under a registered plan, with the issuer identified as the person from whom shares were acquired and consideration described as services rendered. The individual vesting tranches reported are: 1,544 shares on February 28, 2024; 9,578 shares on October 11, 2024; and three separate tranches on February 1, 2025, totaling 33,011, 8,555, and 8,290 shares respectively.
As required by Form 144, the filing also discloses securities sold during the prior three months. Clemens is reported to have sold 169,779 shares on November 5, 2026, generating gross proceeds of $1,260,743.41. The proposed transaction is to be facilitated through Morgan Stanley Smith Barney LLC Executive Financial Services. AdaptHealth Corp. is headquartered at 555 East North Lane, Suite 5075, Conshohocken, Pennsylvania 19428, and the filing carries SEC File Number 001-38399.
What Was Disclosed
A Form 144 notice was filed on November 6, 2026, by Jason A. Clemens, former CFO of AdaptHealth Corp., disclosing a proposed sale of 60,978 common shares valued at $447,510.44, plus a prior sale of 169,779 shares on November 5, 2026.



Please wait processing your request...